中成股份：10月24日召开董事会会议

Group 1 - The core point of the article is that Zhongcheng Co., Ltd. (SZ 000151) held its 30th meeting of the 9th Board of Directors on October 24, 2025, to review the Q3 2025 report [1] - For the first half of 2025, the revenue composition of Zhongcheng Co., Ltd. was as follows: 58.27% from complete equipment import and export, 21.72% from composite materials production, 19.87% from environmental technology, and 0.14% from other businesses [1] - As of the report, Zhongcheng Co., Ltd. has a market capitalization of 4.3 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have sold overseas licenses worth 80 billion USD this year [1] - It highlights a conversation with Lu Gang, a partner at Chuangdong Investment, discussing the hot secondary market for biomedicine while the primary market faces fundraising challenges [1]